Cell Biotech Co., Ltd. (KOSDAQ:049960)

Market Cap	98.55B +4.6%
Revenue (ttm)	50.65B -3.7%
Net Income	12.59B +14.7%
EPS	1,839.56 +14.7%
Shares Out	6.84M
PE Ratio	7.83
Forward PE	n/a
Dividend	450.00 (3.08%)
Ex-Dividend Date	Dec 29, 2025

Volume	14,270
Average Volume	40,160
Open	14,390
Previous Close	14,390
Day's Range	14,240 - 14,680
52-Week Range	11,350 - 15,950
Beta	0.36
RSI	57.48
Earnings Date	Feb 13, 2026

About Cell Biotech

Cell Biotech Co., Ltd., a biotechnology company, develops lactic acid bacteria products in South Korea and internationally. It engages in the probiotics, microbiome, and anticancer new drug businesses. The company sells its products through partnerships with multinational companies and local retailers under the DUOLAC, DUOLAB, LACTOClear, and LAB2PRO brand names. Cell Biotech Co., Ltd. was founded in 1995 and is based in Gimpo-si, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1995
• Employees: 101
• Stock Exchange: KOSDAQ
• Ticker Symbol: 049960

Financial Performance

In 2024, Cell Biotech's revenue was 49.91 billion, a decrease of -7.20% compared to the previous year's 53.79 billion. Earnings were 15.13 billion, an increase of 139.96%.